Tustin, CA – Integrium, LLC announced they will be attending the Redefining Early Stage Investments (RESI) Conference on September 13, 2016 in Boston, MA. Integrium has attended numerous RESI Conferences in the past and has been able to develop key relationships through workshops, panels, and group discussions.
Integrium, LLC to Attend RESI Conference, Boston
Integrium, LLC would like to welcome Ying to the Clinical Data Management team with her role as Clinical Data Manager!
Ying focuses on following a healthy life schedule combined with Western and Eastern medicine. She enjoys great tasting food, except ones with strong bitter flavors!
Her favorite vacation spot is any place near water (but staying away from mosquitos) and has traveled to many places including Toronto, Korea, Thailand, Middle and Southwest China, California, Washington D.C., Philadelphia, Boston, and New York.
From Generic Conception to Drug Stores and How to Be the First to File
By: Emily MacHale
July 20, 2016
It’s safe to say that generic medicines have made a huge impact on the pharmaceutical industry over the past three decades. The idea of getting a prescription filled with the same effect and outcome as a brand drug, but at a much lower cost, appears to be the biggest grand slam of them all.
Booming Biosimilars
By Emily MacHale
July 5, 2016
The Biosimilar market is estimated to save the United States over $44 billion by 2024 when many branded biologics are coming off patent protection.
Slightly different from generics and biological reference products, biosimilars are complex in their manufacturing and data, leaving the FDA to confirm its’ safety and efficacy to pass regulations.
Phase I/II Study for Essential Hypertension Screening Performed On Time
By: Emily MacHale
June 29, 2016
Tustin, CA – Integrium Clinical Research announced their on time screening goal completion for their phase I/II study for essential hypertension, with a total of 52 patients. The screenings were completed on two separate days within a two-week time frame, implementing 22 screenings on the first day and 30 screenings on the second day.
Integrium, LLC would like to welcome Greg to the Business Development team!
Greg’s role at Integrium is Senior Director, Business Development, with a focus in late phase clinical trials.
Greg’s favorite food is Chinese, specifically dim sum, and one of the many places he has traveled to is China! A fun fact about Greg is that he has a relative degree of fluency in Cantonese and he lived in Hong Kong for two years.
How to Mind the Gap in Ethnobridging Clinical Trials
By Emily MacHale
June 6, 2016
Why are Ethnobridging clinical trials so vital in the biopharmaceutical industry today? Global companies are consistently collecting Japanese, Chinese, Taiwanese, and Korean early phase data in clinical development to fulfill specific goals.
Marcum MicroCap Conference
MARCUM MICROCAP CONFERENCE
JUNE 2016, NEW YORK
WHEN: June 1-2, 2016
WHERE: Grand Hyatt, New York, NY
DESCRIPTION:
The Marcum MicroCap Conference is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community.
RESI Conference – Houston, TX
RESI Conference
April 2016
Redefining Early
Stage Investments
WHEN: April 11, 2016
WHERE: Houston, TX
DESCRIPTION:
The RESI Conference series brings together fundraising CEOs and early stage investors from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.
Jefferies 2016 Healthcare Conference – New York
WHEN: June 7-10, 2016
WHERE: New York, NY
DESCRIPTION:
Following the success of last year’s event, with nearly 350 participating companies and over 2,500 attendees, the conference will again feature an extensive range of public & private healthcare companies across the biopharmaceuticals, life sciences, healthcare services, healthcare IT and medical technology sectors.
